Trump Signs Order to Fast-Track Psychedelic Therapies for Veterans

President Trump signed an executive order to accelerate research and access to psychedelic medicines—highlighting ibogaine—as potential treatments for serious mental illnesses and focusing on veterans with PTSD and suicide risk. The order directs cross‑agency collaboration (DOJ, HHS, VA, FDA), aims for faster regulatory review through science‑based pathways, and includes a $50 million federal funding commitment for ibogaine research and expanded access in licensed, hospital‑grade settings, all while maintaining rigorous safety standards.